Merkel Cell Carcinoma clinical trials at UCSF

• A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)

  open to eligible people ages 18 years and up

  The purpose of this study is to assess the clinical activity and safety of INCMGA00012 in participants with advanced/metastatic Merkel cell carcinoma (MCC).

  San Francisco, California and other locations

• Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

  Sorry, in progress, not accepting new patients

  This phase II trial studies how well pembrolizumab works in treating patients with Merkel cell cancer that cannot be removed by surgery or controlled with treatment, or has spread to other parts of the body. Pembrolizumab may stimulate the immune system to identify and destroy cancer cells.

  San Francisco, California and other locations

Last updated: March 25, 2020